Tharimmune (THAR) Stock Statistics & Valuation Metrics

Tharimmune has a market cap or net worth of $84.55M. The enterprise value is ―.

Tharimmune has 36,444,786 shares outstanding. The number of shares has decreased by -2.65% in one year.

Tharimmune’s return on equity (ROE) is -9.33 and return on invested capital (ROIC) is -950.86%.

The current PE Ratio of Tharimmune is ―. Tharimmune’s PEG ratio is 0.00237.

In the last 12 months, Tharimmune had revenue of 0.00 and earned -12.20M in profits. Earnings per share was -9.41.

In the last 12 months, operating cash flow was -8.72M and capital expenditures -1.00, giving a free cash flow of -8.72M billion.

Tharimmune pays an annual dividend of ―, resulting in a dividend yield of ―

Tharimmune upcoming earnings date is ―, ―.

Tharimmune as a current ratio of 1.54, with Debt / Equity ratio of 67.98%

In the past 12 months, Tharimmune has paid 0.00 in taxes.

Tharimmune EV to EBITDA ratio is 0.07, with an EV/FCF ratio of 0.09.

Tharimmune has $7.61M in cash and marketable securities with $0.00 in debt, giving a net cash position of $7.61M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Tharimmune is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy